Werner C, Hoffmann MM, Winkler K, et al. Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment. Vasc Pharmacol. 2014;62(2):94102. Norata GD, Tibolla G, Catapano ... General Medicine eJournal, 3 weeks ago
NICE recommends PCSK9 inhibitors for patients not responding to statins - British Medical Journal, 1 month ago
3 images for "kexin"
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia [Original Research Articles]
Mary E. Haas From Division of Endocrinology, Boston Children's Hospital; Department of Pediatrics, Harvard Medical School, MA (M.E.H., A.E.L., X.S., W.-H.L., S.B.B.); Touchstone Diabetes Center, Departments of Internal Medicine and Cell Biology, ...Circulation, 2 days ago
Strengthen China-US Cooperation and Save Our Planet Together--Minister Li Kexin Visits the Smithsonian Conservation Biology Institute
错误：您所请求的网址（URL）无法获取 您所请求的网址（URL）无法获取 当尝试读取以下网址（URL）时： http://www.china-embassy.org/eng/./sgxw/t1362190.htm 发生了下列的错误： Read Error ...China Embassy, 1 month ago
2016/05/04 On April 27,2016, Minister Li Kexin visited Chinese Culture and Community Service Center (CCACC) in Maryland. Minister Li visited its multipurpose room, Peking opera class, art gallery, Pan Asian Health Clinic, etc.and talked to ...China Embassy, 1 month ago
The Medicines Company completed its divestiture of three cardiovascular medications to Chiesi USA Inc. on June 21, one month after the companies agreed to the deal. The Medicines Company said that it had received approximately $264 million in ...Cardiovascular Business, 1 day ago Chiesi agrees to acquire cardiovascular medications from The Medicines Company Cardiovascular Business, 1 month ago
Pfizer Inc. announced two additional phase 3 bococizumab trials, SPIRE-HR (HighRisk) and SPIRE-FH (Familial Hypercholesterolemia), met their primary endpoint, demonstrating a significant reduction in the percent change from baseline in low-density ...PharmaBiz, 2 days ago Pfizer reports positive Phase III trial results of bococizumab to treat cardiovascular events Drug Development Technology, 2 days ago Pfizer Says SPIRE-HR And SPIRE-FH Trials Meet Primary Endpoints Nasdaq, 3 days ago Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results Enhanced Online News, 3 days ago
Shares of Pfizer Inc. (NYSE:PFE ) ended Tuesday session in green amid volatile trading. The shares closed up +0.64 points or 1.89 % at $ 34.44 with 23.78 million shares getting traded. Post opening the session at $ 34.15 , the shares hit an intraday ...Share Market Updates, 2 days ago PFIZER : Reports first-quarter 2016 results 4 Traders, 1 month ago Pfizer Reports First-Quarter 2016 Results [Global Data Point] Pharmacy Choice, 1 month ago
The Global Pressure Vessel Industry Report 2016 is a professional and in-depth study on the current state of the Pressure Vessel industry. The report provides a basic overview of the industry including definitions, classifications, applications and ...MyNewsDesk, 4 days ago
[embedded content] Zachary T. Bloomgarden, MD, MACE: There's a misconception that fibrates, as a class, are associated with adverse muscle reactions to statins. In fact, this is absolutely a finding with gemfibrozil. [However], with fenofibrate, a ...American Journal of Managed Care, 1 week ago
China Aluminum Boron Alloy Industry 2016 - Production, Sales, Market Share, Consumption, Import, Export, Price (USD/MT), Cost, Gross Margin: Global QY Research
The recently published report titled China Aluminum Boron Alloy Industry 2016 Market Research Report is an in depth study providing complete analysis of the industry for the period 2016 2021. It provides complete overview of China Aluminum Boron ...MyNewsDesk, 1 week ago Global Aluminum Boron Alloy Consumption Sales, Ex-factory Price, Revenue, Gross Margin Analysis 2016 Press Release Ping, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!